Drug Index


Mechanism :

Caspofungin acetate inhibits the synthesis of b (1,3)-D-glucan, an essential component of the cell wall of susceptible Aspergillus species and Candida species. b (1,3)-D-glucan is not present in mammalian cells. Caspofungin has shown activity against Candida species and in regions of active cell growth of the hyphae of Aspergillus fumigatus.

Indication :

  • Treatment of candidemia and invasive candidiasis.
  • Treatment of invasive aspergillosis in patients who are refractory to or intolerant of other therapies.

Contraindications :

Caspofungin is contraindicated in patients with hypersensitivity to any component of this product.

Dosing :

>3 months:
Loading dose:
70 mg/m²/day on day 1, max 70 mg, followed by 50 mg/m²/day, Max: 50 mg OD.
Duration of treatment should be based on the patients clinical response.

Adverse Effect :

Histamine-mediated symptoms of rash, facial swelling, pruritus, sensation of warmth, or bronchospasm, anaphylaxis.

Interaction :

For patients receiving both therapies, standard monitoring of tacrolimus blood concentrations and appropriate tacrolimus dosage adjustments are recommended.
Cyclosporine (one 4 mg/kg dose or two 3 mg/kg doses): Increased the AUC of caspofungin by approximately 35% There were transient increases in liver ALT and AST when co-administered.
Rifampin: A drug-drug interaction study with rifampin in healthy volunteers has shown a 30% decrease in caspofungin trough concentrations.
Inducers of drug clearance: Co-administration of other inducers of drug clearance (efavirenz, nevirapine, phenytoin, dexamethasone, or carbamazepine) may result in clinically meaningful reductions in caspofungin concentrations. Use of a daily dose of 70 mg should be considered.

Renal Dose :

Dose in Renal Impairment GFR (mL/min)
20-50Dose as in normal renal function
10-20Dose as in normal renal function
<10Dose as in normal renal function

Dose in Patients undergoing Renal Replacement Therapies
CAPDNot dialysed. Dose as in normal renal function
HDNot dialysed. Dose as in normal renal function
HDF/High fluxUnlikely to be dialysed. Dose as in normal renal function
CAV/VVHDNot dialysed. Dose as in normal renal function

Hepatic Dose :

Mild hepatic impairment: No dose adjustment needed.
Moderate hepatic impairment: No change in loading dose needed. Give maintenance dose of 35 mg/sqm/day.
Severer hepatic impairment: No data available.
01/30/2023 09:37:52 Caspofungin
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0